Rheonix STI Rheonix STI TriPlex™ Assay

True walkaway automation

Provides fully automated detection of three of the most prevalent sexually transmitted infections (STIs) in a single test. Detects and differentiates Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) in male urine specimens.

For use with the Rheonix Encompass MDx® workstation and the Rheonix Urine Specimen Collection Kit.

Press Release

Contact Sales

in-vitro diagnostic Approved for in-vitro diagnostic use.



Encompass MDx® STI card


Simple, Intuitive Workflow

Workflow diagram

Key Benefits

robot arm

True walkaway automation


Low cost

Low cost


Target

Detects and differentiates CT, NG, and TV with a single test


Test Tube

Easy sample collection


Scaling

Highly scalable system

The Need

In 2019, for the sixth consecutive year, sexually transmitted infections were at an all-time high.1 Among the most prevalent and treatable infections are Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV). The need for STI testing has intensified during the COVID-19 pandemic due to competing demands on the public health and clinical testing sectors. Failure to diagnose and treat STIs may lead to longer term health consequences in both men and women, as well as contribute to the spread of these infections to sexual partners. Gay and Bisexual men may be at higher risk; for example, in some areas, gonorrhea rates are 42 times that of heterosexual men.2

1. www.cdc.gov/std
2. www.cdc.gov/media/releases/2021/p0413-stds.html

CDC Overview Stats Graphic

www.cdc.gov/std/statistics/prevalence-2020-at-a-glance.htm

Encompass MDx® card